Klacid Od

Clarithromycin, the active ingredient in Klacid Od, is a macrolide antibiotic presented as an oral dosage form for systemic use. It treats a range of bacterial infections, including community‑acquired pneumonia, acute bacterial sinusitis, and skin and soft‑tissue infections, and is prescribed for adult and pediatric patients when indicated by a healthcare professional.

GNH USA supplies Klacid Od as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide through regulated supply chains that meet global quality standards and reliable logistics.

Clarithromycin is a macrolide antibiotic used to treat bacterial infections in the respiratory, gastrointestinal and skin categories.

- Community‑acquired pneumonia: reduces bacterial load and improves clinical outcomes in adults. - Acute bacterial sinusitis: eradicates the causative pathogens and relieves sinus inflammation. - Acute bacterial exacerbations of chronic bronchitis: shortens the duration of symptoms and prevents further lung damage. - Skin and soft‑tissue infections: eliminates susceptible Gram‑positive and some Gram‑negative organisms. - Helicobacter pylori eradication regimens: contributes to bacterial clearance when combined with other agents.

Clarithromycin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: transient gastrointestinal discomfort. - Diarrhea: loose stools that may be mild to moderate. - Abdominal pain: cramping or discomfort in the stomach area. - Taste disturbance: altered or metallic taste perception. - Headache: mild to moderate intensity. - Vomiting: occasional episodes of emesis.

Serious or Rare Side Effects: - Severe allergic reactions: rash, itching, swelling, or anaphylaxis. - Clostridioides difficile‑associated diarrhea: severe colitis requiring medical attention. - Liver enzyme elevation: potential hepatotoxicity indicated by increased transaminases. - QT interval prolongation: risk of cardiac arrhythmias. - Cardiac arrhythmias: including torsades de pointes in susceptible patients.

Before prescribing Klacid Od, clinicians should consider several safety aspects.

- Assess renal and hepatic function: adjust therapy if impairment is present. - Avoid use in patients with known macrolide hypersensitivity: risk of severe allergic reactions. - Monitor cardiac rhythm in patients with QT prolongation risk: potential for arrhythmias. - Use with caution in pregnancy: limited data, weigh benefits against potential risks. - Store at room temperature: keep in the original pack, protect from moisture and light.

Clarithromycin can interact with several medications, requiring careful management.

Major Interactions (Avoid): - Cisapride: may cause serious cardiac arrhythmias. - Ergot alkaloids: risk of vasospasm and ischemia. - Theophylline: increased plasma concentrations leading to toxicity. - Pimozide: heightened risk of QT prolongation.

Moderate Interactions (Monitor Closely): - Warfarin: may enhance anticoagulant effect, requiring INR monitoring. - Simvastatin: increased risk of myopathy, consider dose adjustment. - Carbamazepine: may reduce clarithromycin levels, affecting efficacy.